These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 8519415)
21. Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer. Heidenreich B; Heidenreich A; Sesterhenn A; Srivastava S; Moul JW; Sesterhenn IA Eur Urol; 2000 Oct; 38(4):475-82. PubMed ID: 11025389 [TBL] [Abstract][Full Text] [Related]
22. Alterations of CDKN2 (p16) in non-small cell lung cancer. de Vos S; Miller CW; Takeuchi S; Gombart AF; Cho SK; Koeffler HP Genes Chromosomes Cancer; 1995 Nov; 14(3):164-70. PubMed ID: 8589032 [TBL] [Abstract][Full Text] [Related]
23. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions. Kumanishi T; Zhang S; Ichikawa T; Endo S; Washiyama K Jpn J Cancer Res; 1996 Jul; 87(7):691-5. PubMed ID: 8698617 [TBL] [Abstract][Full Text] [Related]
24. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987 [TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056 [TBL] [Abstract][Full Text] [Related]
26. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas. Tenan M; Benedetti S; Finocchiaro G Biochem Biophys Res Commun; 1995 Dec; 217(1):195-202. PubMed ID: 8526910 [TBL] [Abstract][Full Text] [Related]
27. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670 [TBL] [Abstract][Full Text] [Related]
28. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Xiao S; Li D; Corson JM; Vijg J; Fletcher JA Cancer Res; 1995 Jul; 55(14):2968-71. PubMed ID: 7606711 [TBL] [Abstract][Full Text] [Related]
29. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Naumann M; Savitskaia N; Eilert C; Schramm A; Kalthoff H; Schmiegel W Gastroenterology; 1996 Apr; 110(4):1215-24. PubMed ID: 8613012 [TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of INK4 genes in breast carcinomas. Spirin K; Simpson J; Miller C; Koeffler H Int J Oncol; 1997 Oct; 11(4):737-44. PubMed ID: 21528268 [TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors. Zariwala M; Liu E; Xiong Y Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224 [TBL] [Abstract][Full Text] [Related]
32. Role of the cyclin-dependent kinase 4 and 6 inhibitor gene family p15, p16, p18 and p19 in leukemia and lymphoma. Siebert R; Willers CP; Opalka B Leuk Lymphoma; 1996 Nov; 23(5-6):505-20. PubMed ID: 9031081 [TBL] [Abstract][Full Text] [Related]
33. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C). Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039 [TBL] [Abstract][Full Text] [Related]
34. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381 [TBL] [Abstract][Full Text] [Related]
35. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289 [TBL] [Abstract][Full Text] [Related]
36. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
37. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors. Ichikawa Y; Yoshida S; Koyama Y; Hirai M; Ishikawa T; Nishida M; Tsunoda H; Kubo T; Miwa M; Uchida K Int J Cancer; 1996 Dec; 69(6):466-70. PubMed ID: 8980248 [TBL] [Abstract][Full Text] [Related]
38. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963 [TBL] [Abstract][Full Text] [Related]
39. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L; Eymin B; Brambilla E; Gazzeri S Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784 [TBL] [Abstract][Full Text] [Related]
40. The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Diccianni MB; Chau LS; Batova A; Vu TQ; Yu AL Cancer Lett; 1996 Jul; 104(2):183-92. PubMed ID: 8665486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]